Back to search

The impact of hemoglobin levels on treatment outcomes in patients with cancer

Data up to Jan 2025

Published2001
Citations106
References31

Total Citations Per Year

Abstract

References (31)

Radiobiology for the Radiologist.

1974 • 3,582 citations

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

1989 • 3,308 citations

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

1996 • 1,747 citations

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1997 • 1,057 citations

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Chemotherapy-Induced Anemia in Adults: Incidence and Treatment

1999 • 918 citations

Transfusion Medicine — Blood Transfusion

1999 • 894 citations

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1998 • 769 citations

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

1991 • 732 citations

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

1997 • 715 citations

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

2001 • 606 citations

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1999 • 430 citations

Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.

1990 • 222 citations

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27

1998 • 206 citations

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients

1989 • 169 citations

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

2000 • 163 citations

A new staging system for multiple myeloma based on the number of S- phase plasma cells

1995 • 143 citations

Erythropoietin increases hemoglobin in cancer patients during radiation therapy

1993 • 126 citations

Erythropoietin increases hemoglobin during radiation therapy for cervical cancer

1994 • 126 citations

Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.

1992 • 119 citations

Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats.

1996 • 117 citations

The oxygen effect and reoxygenation

1975 • 117 citations

Radiotherapy and anaemia — the clinical experience

1991 • 110 citations

The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma

1992 • 100 citations

Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx

1997 • 84 citations

MRI-assisted specification/localization of target volumes. Aspects of quality control.

1998 • 80 citations

On the quality of treatment planning systems in radiation therapy.

1998 • 68 citations

Does p53 status influence tumor response to anticancer therapies?

2000 • 64 citations

Clinical trial experience using erythropoietin during radiation therapy.

1998 • 44 citations

Prognostic Factors for Survival in Inoperable Non-Small-Cell Lung Cancer: A Multivariate Regression Analysis of 456 Patients with Radiation Therapy

1997 • 35 citations

Anemia associated with non-platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)

1999 • 16 citations

Cited By (0)

Loading...